Tenon Medical, Inc. (TNON)

US — Healthcare Sector
Peers: BJDX  HSCS  IRIX  MOTS  NXL  OKYO  OST  XPON 

Automate Your Wheel Strategy on TNON

With Tiblio's Option Bot, you can configure your own wheel strategy including TNON - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TNON
  • Rev/Share 0.913
  • Book/Share 2.6066
  • PB 0.3913
  • Debt/Equity 0.0384
  • CurrentRatio 5.4624
  • ROIC -1.2022

 

  • MktCap 7741769.0
  • FreeCF/Share -2.8051
  • PFCF -0.7673
  • PE -0.2676
  • Debt/Assets 0.0269
  • DivYield 0
  • ROE -2.2508

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
TNON
Published: March 25, 2025 by: Accesswire
Sentiment: Neutral

LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 1,271,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00. In a concurrent private placement (the "Private Placement" and together with the registered offering, the …

Read More
image for news Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
TNON
Published: March 25, 2025 by: Accesswire
Sentiment: Neutral

LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 733,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00. In a concurrent private placement (the "Private Placement" and together with the registered offering, the …

Read More
image for news Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

About Tenon Medical, Inc. (TNON)

  • IPO Date 2022-04-27
  • Website https://www.tenonmed.com
  • Industry Medical - Devices
  • CEO Steven M. Foster
  • Employees 27

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.